{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:25:32Z","timestamp":1793856332754,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117541","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:04:00Z","timestamp":1792271040000},"page":"117541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Complement C3a plays a role in diabetic cardiomyopathy mainly via C3aR-ERK-PANoptosis pathway"],"prefix":"10.1016","volume":"190","author":[{"given":"Yueqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Vaczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Atlasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.intimp.2026.117541_bb0005","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/ejhf.3347","article-title":"Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & pericardial diseases","volume":"26","author":"Seferovi\u0107","year":"2024","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.intimp.2026.117541_bb0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S2213-8587(23)00128-6","article-title":"Predicting and preventing heart failure in type 2 diabetes","volume":"11","author":"Pandey","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117541_bb0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117541_bb0020","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2026.117541_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154918","article-title":"Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease","volume":"126","author":"Liu","year":"2022","journal-title":"Metab. Clin. Exp."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molmed.2023.10.001","article-title":"Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes","volume":"30","author":"Pandeya","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"7876","key":"10.1016\/j.intimp.2026.117541_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","article-title":"AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence","volume":"597","author":"Lee","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117541_bb0040","article-title":"Advances in mechanism and regulation of PANoptosis: prospects in disease treatment","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"issue":"74","key":"10.1016\/j.intimp.2026.117541_bb0045","doi-asserted-by":"crossref","first-page":"eabo6294","DOI":"10.1126\/sciimmunol.abo6294","article-title":"ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection","volume":"7","author":"Karki","year":"2022","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/imr.12909","article-title":"The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)","volume":"297","author":"Zheng","year":"2020","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.13279","article-title":"PANoptosis: mechanisms, biology, and role in disease","volume":"321","author":"Sun","year":"2024","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2026.117541_bb0060","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/er.2014-1099","article-title":"Role of complement and complement regulatory proteins in the complications of diabetes","volume":"36","author":"Ghosh","year":"2015","journal-title":"Endocr. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2026.117541_bb0065","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117541_bb0070","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","article-title":"The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts","volume":"54","author":"Fri\u0161\u010di\u0107","year":"2021","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.intimp.2026.117541_bb0075","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-023-01339-w","article-title":"Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins","volume":"19","author":"Wang","year":"2023","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0080","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140966","article-title":"Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging","volume":"131","author":"Propson","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"Pt 2","key":"10.1016\/j.intimp.2026.117541_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbrc.2022.05.001","article-title":"Dickkopf-1 exerts protective effects by inhibiting PANoptosis and retinal neovascularization in diabetic retinopathy","volume":"617","author":"Xu","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2026.117541_bb0090","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41419-022-05460-x","article-title":"FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM","volume":"13","author":"Bi","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0095","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1038\/s41467-022-33152-9","article-title":"The complement C3-complement factor D-C3a receptor signalling axis regulates cardiac remodelling in right ventricular failure","volume":"13","author":"Ito","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12967-023-04741-z","article-title":"A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway","volume":"22","author":"Dai","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12872-024-04010-x","article-title":"Effect of NLRP3 gene knockdown on pyroptosis and ferroptosis in diabetic cardiomyopathy injury","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12933-022-01602-9","article-title":"MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes","volume":"21","author":"Cao","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117541_bb0115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: a defence system turning offensive","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0120","doi-asserted-by":"crossref","first-page":"19202","DOI":"10.1038\/s41598-019-55727-1","article-title":"Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction","volume":"9","author":"Cuvelliez","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2026.117541_bb0125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbrc.2020.01.018","article-title":"Complement component C3 and the TLR co-receptor CD14 are not involved in angiotensin II induced cardiac remodelling","volume":"523","author":"Shahini","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2026.117541_bb0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ajh\/hpt274","article-title":"Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension","volume":"27","author":"Zhang","year":"2014","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"10.1016\/j.intimp.2026.117541_bb0135","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/ATVBAHA.113.303120","article-title":"Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling","volume":"34","author":"Zhang","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117541_bb0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2021.12.040","article-title":"Complement activation induces excessive T cell cytotoxicity in severe COVID-19","volume":"185","author":"Georg","year":"2022","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.intimp.2026.117541_bb0145","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1681\/ASN.2021101384","article-title":"Complement C3a and C3a receptor activation mediates podocyte injuries in the mechanism of primary membranous nephropathy","volume":"33","author":"Gao","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117541_bb0150","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167501","article-title":"Complement C3aR depletion reverses HIF-1\u03b1-induced metabolic impairment and enhances microglial response to a\u03b2 pathology","volume":"133","author":"Gedam","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2026.117541_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101989","article-title":"ERK\/RSK-mediated phosphorylation of Y-box binding protein-1 aggravates diabetic cardiomyopathy by suppressing its interaction with deubiquitinase OTUB1","volume":"298","author":"Zhong","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2026.117541_bb0160","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.7150\/ijbs.60459","article-title":"The MEK inhibitor U0126 ameliorates diabetic cardiomyopathy by restricting XBP1's phosphorylation dependent SUMOylation","volume":"17","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117541_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s44161-024-00428-w","article-title":"YAP induces a neonatal-like pro-renewal niche in the adult heart","volume":"3","author":"Li","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117541_bb0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41420-024-01978-5","article-title":"The role of IFI16 in regulating PANoptosis and implication in heart diseases","volume":"10","author":"Chang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.117541_bb0175","article-title":"Targeting the PANoptosis signaling pathway for myocardial protection: therapeutic potential of xian Ling Gu bao capsule","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117541_bb0180","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.2147\/JIR.S442260","article-title":"A pilot study about the role of PANoptosis-based genes in atherosclerosis development","volume":"16","author":"Chen","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2026.117541_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2024.123713","article-title":"Polystyrene nanoplastics and cadmium co-exposure aggravated cardiomyocyte damage in mice by regulating PANoptosis pathway","volume":"347","author":"Ye","year":"2024","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.intimp.2026.117541_bb0190","article-title":"The \"C3aR antagonist\" SB290157 is a partial C5aR2 agonist","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117541_bb0195","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/eci.12419","article-title":"Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention","volume":"45","author":"Mastellos","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"issue":"14","key":"10.1016\/j.intimp.2026.117541_bb0200","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1021\/acs.jmedchem.8b00560","article-title":"New analogs of the complement C3 inhibitor compstatin with increased solubility and improved pharmacokinetic profile","volume":"61","author":"Berger","year":"2018","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2026.117541_bb0205","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0161-5890(02)00212-2","article-title":"Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3","volume":"39","author":"Sahu","year":"2003","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.117541_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02385","article-title":"Complement C3 produced by macrophages promotes renal fibrosis via IL-17A secretion","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:49:51Z","timestamp":1793854191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"alternative-id":["S1567576926013895"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117541","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement C3a plays a role in diabetic cardiomyopathy mainly via C3aR-ERK-PANoptosis pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117541"}}